Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00764673 · ClinicalTrials.gov registry record · Phase 4
The 3DKnee™ System: A Post-Market Study
A Phase 4 study, sponsored by Encore Medical, L.P..
- Completed
- Registry status
- Phase 4
- Development phase
- 71
- Enrollment target
NCT00764673 is a Phase 4 study that has completed, run by Encore Medical, L.P.. The registered enrollment target is 71 participants.
The verdict
NCT00764673, a Phase 4 study, has completed, sponsored by Encore Medical, L.P..
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 71 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the survivorship and efficacy of the Encore 3DKnee™ system in a group of patients who will receive the 3DKnee™ as a primary (first) orthopedic implant in the knee. Each knee will be designated as a separate subject and followed for a period of 2 years.
Interventions
- DEVICE 3DKnee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2006-10 |
| Est. Completion | 2010-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00764673
The ClinicalTrials.gov registry entry for NCT00764673 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Encore Medical, L.P., which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 3DKnee is the first listed.
NCT00764673 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00764673 about?
NCT00764673 is a clinical study titled "The 3DKnee™ System: A Post-Market Study". The purpose of this study is to evaluate the survivorship and efficacy of the Encore 3DKnee™ system in a group of patients who will receive the 3DKnee™ as a primary (first) orthopedic implant in the knee. Each knee will be designated as a separate subject and followed for a period of 2 years.
What is the current status of trial NCT00764673?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 71 participants. The study started on 2006-10. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00764673?
The interventions under investigation include: 3DKnee (DEVICE).
Who is sponsoring clinical trial NCT00764673?
This trial is sponsored by Encore Medical, L.P., which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.